NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma.
Saved in:
| Title: | NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma. |
|---|---|
| Authors: | Lee EQ; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Zhang P; NRG Oncology Statistics and Data Management Center, American College of Radiology, Philadelphia, Pennsylvania., Wen PY; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Gerstner ER; Massachusetts General Hospital, Boston, Massachusetts., Reardon DA; Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts., Aldape KD; Toronto General Hospital, Toronto, Ontario, Canada., deGroot JF; The University of Texas MD Anderson Cancer Center, Houston, Texas., Pan E; University of Texas Southwestern Medical Center, Dallas, Texas., Raizer JJ; Northwestern University, Evanston, Illinois., Kim LJ; Thomas Jefferson University Hospital, Philadelphia, Pennsylvania., Chmura SJ; University of Chicago Comprehensive Cancer Center, Chicago, Illinois., Robins HI; University of Wisconsin Hospital and Clinics, Madison, Wisconsin., Connelly JM; Froedtert and the Medical College of Wisconsin, Milwaukee, Wisconsin., Battiste JD; University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Villano JL; University of Kentucky, Lexington, Kentucky., Wagle N; University of Southern California, Los Angeles, California., Merrell RT; North Shore University Health System, Evanston, Illinois., Wendland MM; The US Oncology Network-Willamette Valley Cancer Institute, Eugene, Oregon., Mehta MP; Baptist Hospital of Miami, Miami, Florida. |
| Source: | Cancer [Cancer] 2020 Jun 15; Vol. 126 (12), pp. 2821-2828. Date of Electronic Publication: 2020 Mar 10. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0142 |
|---|---|
| DOI: | 10.1002/cncr.32811 |
